175 related articles for article (PubMed ID: 36067080)
1. Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?
Kalver E; Branch-Elliman W; Stolzmann K; Wachterman M; Shin MH; Schweizer ML; Mull HJ
J Palliat Med; 2023 Feb; 26(2):175-181. PubMed ID: 36067080
[No Abstract] [Full Text] [Related]
2. One-year mortality after implantable cardioverter-defibrillator placement within the Veterans Affairs Health System.
Fudim M; Carlisle MA; Devaraj S; Ajam T; Ambrosy AP; Pokorney SD; Al-Khatib SM; Kamalesh M
Eur J Heart Fail; 2020 May; 22(5):859-867. PubMed ID: 32108984
[TBL] [Abstract][Full Text] [Related]
3. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
Healy CA; Carrillo RG
Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
[TBL] [Abstract][Full Text] [Related]
4. Mortality after cardioverter-defibrillator replacement: Results of the DECODE survival score index.
Zoni-Berisso M; Martignani C; Ammendola E; Narducci ML; Caruso D; Miracapillo G; Notarstefano P; Carinci V; Pierantozzi A; Ciaramitaro G; Calò L; Zennaro M; Infusino T; Ferretti C; Sassone B; Licciardello G; Setti S; Terzaghi C; Malacrida M; Biffi M
Heart Rhythm; 2021 Mar; 18(3):411-418. PubMed ID: 33249200
[TBL] [Abstract][Full Text] [Related]
5. Use of a regional wall motion score to enhance risk stratification of patients receiving an implantable cardioverter-defibrillator.
Nath S; DeLacey WA; Haines DE; Berry VA; Barber MJ; Kron IL; DiMarco JP
J Am Coll Cardiol; 1993 Oct; 22(4):1093-9. PubMed ID: 8409046
[TBL] [Abstract][Full Text] [Related]
6. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
[TBL] [Abstract][Full Text] [Related]
7. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
Chan PS; Hayward RA
J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
[TBL] [Abstract][Full Text] [Related]
9. Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.
Forman J; Baumbusch J; Jackson H; Lindenberg J; Shook A; Bashir J
Eur J Cardiovasc Nurs; 2018 Dec; 17(8):698-706. PubMed ID: 29775072
[TBL] [Abstract][Full Text] [Related]
10. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
11. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation.
Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372
[TBL] [Abstract][Full Text] [Related]
12. Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.
Anderson MH; Camm AJ
Br Heart J; 1993 Jan; 69(1):83-92. PubMed ID: 8457402
[TBL] [Abstract][Full Text] [Related]
13. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
15. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
Fluur C; Bolse K; Strömberg A; Thylén I
J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
17. Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients.
Rorris FP; Charitos C
Heart Fail Rev; 2021 Jul; 26(4):763-765. PubMed ID: 33404997
[TBL] [Abstract][Full Text] [Related]
18. Information provision and follow-up of French patients with implantable cardioverter-defibrillators: The APODEC survey.
Halin A; Hamelin JL; Defaye P; Deharo JC; Fauchier L; Marijon E; Piot O; Boveda S
Arch Cardiovasc Dis; 2023 Dec; 116(12):572-579. PubMed ID: 37953189
[TBL] [Abstract][Full Text] [Related]
19. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
Herman M; Horner K; Ly J; Vayl Y
J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
[TBL] [Abstract][Full Text] [Related]
20. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
